Whitepapers

Innovative qPCR tools for your bioanalysis and quality control. Fast-track your bioanalysis & QC with scalable innovative qPCR tools.

TaqMan SNP Genotyping Assays help you detect and distinguish single-nucleotide polymorphisms (SNPs) accurately and efficiently.

Multiplex better with the newest additions to the TaqMan portfolio

Partnering with a CDMO can help streamline drug development, and certain preparations can help ensure a successful collaboration. Scott Alderucci, Curia’s Director of Process Development, explores the advantages of partnering with a CDMO to navigate the journey from molecule conception to clinical trials, including the expertise, experience, and preparedness that a CDMO brings to the table.

Discover how to accurately analyze purity and impurities, determine sequences, and more with next-generation technologies from Agilent.

Key strategies for accelerating development and manufacturing and development timelines to bring drugs to market faster and give developers a competitive advantage.

Now supplying cleanroom doors, panels and accessories for all cleanroom applications.

The first of its kind prefabricated cleanroom system that integrates with the host facility floor.

Implementing automation involves careful optimization and fine-tuning of various parameters to ensure the accurate execution of cell-based potency assays.

G-CON Clean Solutions has a best in class offering of cleanroom doors, panels and accessories for all cleanroom applications.

A step-by-step path to building confidence in packaging component selection for injectable drugs

Ensure the success of clinical biomanufacturing programs by focusing on key tech transfer practices from the sponsor, commercial, scientific, and program management stakeholders.

Partnering with a CDMO with collective insights and capabilities to support the development and manufacture of an innovative biotherapeutic program is an essential first step to providing better care to patients.

As pipettes touch virtually every experiment, they influence the accuracy and repeatability of the experimental data.

This application note presents a protocol for Sf9 insect cell culture in stirred-tank bioreactors and recombinant protein production via a baculovirus vector system.

Discover how ReciBioPharm’s strategic approach helped to support the rapid delivery of an innovative oncolytic adenovirus therapy for advanced cancer to clinic.

Leveraging digital transformation and preparing for the lab of the future, LabVantage Solutions has devised a five-step process to successfully implement AI in the lab.

Discover how high-resolution biomarker assays such as Meso Scale Discovery (MSD) and advanced Mass Spectrometry (MS) go beyond the limitations of traditional ELISA assays, and how they overcome central challenges in biomarker assessment and ligand binding assays (LBAs).

This article explores process modeling and compares process economics between a conventional upstream process and three perfused seed train alternatives

This white paper provides an overview on an enabling cell retention solution resulting in greater cell-mass to achieve significantly higher titers.

In this white paper, we discuss seed train intensification strategies to leverage productivity increases and drive down costs.

Discover the benefits of using next generation processes and options to consider towards your path to upstream success.

We explore seed train intensification approaches which deliver significant upstream process improvements in speed, flexibility and reliability.